HRA pharma has announced the resignation of David Wright who moves on after serving the company for more than five years as chief executive officer.
The company has appointed Martyn Hilton, chief commercial officer for HRA Pharma, as interim CEO effective from September 1, 2022.
David helmed the company during a period of transformation and set the course for its tremendous growth, elevating HRA Pharma into a leading provider of
over-the-counter self-care products.
He commented: "Given the significant progress HRA has made, along with my personal goals after leading HRA for more than five years, I believe now is the time to
step away from the business.
"I am proud of all that we have accomplished, making HRA well-known for its Women's Health, Wound Care and Scar Care leadership, operating via brands including
ellaOne, Hana, Compeed and Mederma. I appreciate all the team members involved in the success of the organization and believe Perrigo and HRA are well-positioned
to elevate this business and these brands to the next level."
Ceuta Group, a global brand building business providing end-to-end outsourcing services in the health and wellness industry has appointed David Wright as a
non-executive board director.
With extensive experience of leading global consumer healthcare companies, David joins Ceuta Group following five years as CEO/President of global pharmaceutical
company, HRA Pharma and six years as Global Head of Boehringer Ingelheim's consumer business.
During his time at HRA Pharma and Boehringer Ingelheim GmBH, David led both companies through substantial organisational and strategy re-design which led to
sustainable growth and profitability.
The company said: "David has a strong belief that combining the right structure, operational priorities and processes, with a strong focus on company culture, are
critical factors in building successful businesses. This approach saw him lead a period of transformation at HRA Pharma resulting in the company's successful
acquisition by Perrigo Company plc."
David will take an active role on the Ceuta Group Board supporting and building the company's strategic vision and priorities. He will also help shape the company's
growth plans on an operational level to ensure Ceuta Group continues to meet client's needs today and into the future.